養雞產業股持續大漲 立華股份、益生股份封漲停
格隆匯10月25日丨養雞產業股持續大漲,益生股份漲停,股價創歷史新高,年初至今漲幅超300%;立華股份漲停,仙壇股份、民和股份等漲幅居前。

近期雞產業板塊持續上漲,本週以來累計上漲超21%,今年以來累計漲幅超144%。

消息面上,從3月中旬以來持續處於靜默期的雞產業鏈股票集體上揚。產業景氣度超預期成為這波上漲的底層邏輯,雞肉、雞蛋、雞苗價格均創出歷史新高,而且一再刷新。在業績被刷新的同時,相關公司股票也受到融資客以及北上資金持續青睞。
分析人士表示,雞價上漲勢頭強勁,禽產業鏈量價齊升的景氣週期有望持續。從供給端看,目前階段新建規模養殖場投產增多、雞苗需求較好,但由於種雞疾病影響,雞苗增幅有限,預計後期苗價有望持續震盪上行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.